2021 IDSA/SHEA临床实践指南:成人艰难梭菌感染的管理(更新版)

2021-06-24 美国感染病学会 Clin Infect Dis.2021 Jun 24;

2021年6月,美国感染病学会(IDSA)联合美国医疗保健流行病学学会(SHEA)更新发布了成人艰难梭菌感染的管理指南。指南主要聚焦了非达霉素和bezlotoxumab在治疗艰难梭菌感染中的应用。

中文标题:

2021 IDSA/SHEA临床实践指南:成人艰难梭菌感染的管理(更新版)

英文标题:

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

发布机构:

美国感染病学会

发布日期:

2021-06-24

简要介绍:

2021年6月,美国感染病学会(IDSA)联合美国医疗保健流行病学学会(SHEA)更新发布了成人艰难梭菌感染的管理指南。指南主要聚焦了非达霉素和bezlotoxumab在治疗艰难梭菌感染中的应用。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=成人艰难梭菌感染的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7d88a1c002123e00, title=2021 IDSA/SHEA临床实践指南:成人艰难梭菌感染的管理(更新版), enTitle=Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults, guiderFrom=Clin Infect Dis.2021 Jun 24;, authorId=0, author=, summary=2021年6月,美国感染病学会(IDSA)联合美国医疗保健流行病学学会(SHEA)更新发布了成人艰难梭菌感染的管理指南。指南主要聚焦了非达霉素和bezlotoxumab在治疗艰难梭菌感染中的应用。, cover=https://img.medsci.cn/2021630/1625067844580_2020535.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会(IDSA)是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是:为临床增加可靠性证据,促进分享以减少传染病给社会带来的经济负担,促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Thu Jun 24 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,美国感染病学会(IDSA)联合美国医疗保健流行病学学会(SHEA)更新发布了成人艰难梭菌感染的管理指南。指南主要聚焦了非达霉素和bezlotoxumab在治疗艰难梭菌感染中的应用。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=11318, tagName=艰难梭菌感染)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11318, guiderKeyword=艰难梭菌感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7136, appHits=74, showAppHits=0, pcHits=669, showPcHits=7062, likes=0, shares=6, comments=5, approvalStatus=1, publishedTime=Wed Jun 30 23:53:27 CST 2021, publishedTimeString=2021-06-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 30 23:44:17 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:27:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=成人艰难梭菌感染的管理.pdf)])
成人艰难梭菌感染的管理.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1001653, encodeId=99da100165323, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd431762721, createdName=ms1235756297815364, createdTime=Thu Jul 22 11:38:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996111, encodeId=49809961117b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=ms5000001536086898, createdTime=Sun Jul 04 15:39:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978876, encodeId=01ac9e887650, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=851d2168098, createdName=12047707m16暂无昵称, createdTime=Fri Jul 02 08:14:17 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978743, encodeId=228d9e874350, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/744f639c0ac24549ab1e0c4fbb6876ed/9afc870f9e0d45a0963b7dae6cc8c8b2.jpg, createdBy=11b55161224, createdName=王子燕窝, createdTime=Thu Jul 01 20:37:33 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-22 ms1235756297815364

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1001653, encodeId=99da100165323, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd431762721, createdName=ms1235756297815364, createdTime=Thu Jul 22 11:38:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996111, encodeId=49809961117b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=ms5000001536086898, createdTime=Sun Jul 04 15:39:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978876, encodeId=01ac9e887650, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=851d2168098, createdName=12047707m16暂无昵称, createdTime=Fri Jul 02 08:14:17 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978743, encodeId=228d9e874350, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/744f639c0ac24549ab1e0c4fbb6876ed/9afc870f9e0d45a0963b7dae6cc8c8b2.jpg, createdBy=11b55161224, createdName=王子燕窝, createdTime=Thu Jul 01 20:37:33 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-04 ms5000001536086898

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1001653, encodeId=99da100165323, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd431762721, createdName=ms1235756297815364, createdTime=Thu Jul 22 11:38:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996111, encodeId=49809961117b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=ms5000001536086898, createdTime=Sun Jul 04 15:39:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978876, encodeId=01ac9e887650, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=851d2168098, createdName=12047707m16暂无昵称, createdTime=Fri Jul 02 08:14:17 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978743, encodeId=228d9e874350, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/744f639c0ac24549ab1e0c4fbb6876ed/9afc870f9e0d45a0963b7dae6cc8c8b2.jpg, createdBy=11b55161224, createdName=王子燕窝, createdTime=Thu Jul 01 20:37:33 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-02 12047707m16暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1001653, encodeId=99da100165323, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd431762721, createdName=ms1235756297815364, createdTime=Thu Jul 22 11:38:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996111, encodeId=49809961117b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=ms5000001536086898, createdTime=Sun Jul 04 15:39:00 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978876, encodeId=01ac9e887650, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=851d2168098, createdName=12047707m16暂无昵称, createdTime=Fri Jul 02 08:14:17 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978743, encodeId=228d9e874350, content=受益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/744f639c0ac24549ab1e0c4fbb6876ed/9afc870f9e0d45a0963b7dae6cc8c8b2.jpg, createdBy=11b55161224, createdName=王子燕窝, createdTime=Thu Jul 01 20:37:33 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-01 王子燕窝

    受益了

    0

拓展阅读

2017 IDSA/SHEA临床实践指南:成人和儿童艰难梭菌感染的管理(更新版)

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2018-02-15

2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防

欧洲艰难梭菌研究小组(ESGCD,European Study Group for C. difficile) · 2018-03-02

2018 BSG/HIS指南:粪菌移植治疗复发性难治性艰难梭菌感染以及其他潜在并发症

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2018-08-25

2018 AMMI实践指南:艰难梭菌感染的治疗

加拿大医学微生物与感染病协会(AMMI,Association of Medical Microbiology and Infectious Disease Canada) · 2018-06-29

2019 ASID/ACIPC立场声明:医疗机构内艰难梭菌感染患者的感染控制

澳大利亚传染病协会(ASID,Australasian Society for Infectious Diseases) · 2019-01-30

2019 WSES指南:手术患者艰难梭菌感染的管理(更新)

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2019-02-28